Innervace
Nader Halim is the current Chief Executive Officer at Innervace and also serves as a Business Development Consultant. Prior to their current role, Nader was the Vice President of R&D Strategy and Operations at Repertoire Immune Medicines. Nader has extensive experience in strategy and business development, having held positions such as Vice President of Strategy at Verana Health and Search and Evaluation Senior Director at Pfizer. Additionally, Nader has a background in academia and research, having worked as a Biologist at the National Institutes of Health. Nader holds a PhD in Molecular and Cell Biology, an MPH in Health Economics, an MBA in Healthcare Management, and a BS in Biology.
This person is not in any teams
This person is not in any offices
Innervace
Innervace is a developer of a regenerative therapy company designed to develop implantable tissue-engineered brain pathways for neurodegenerative disorders.The company is focused on the development and commercialization of anatomically inspired living scaffolds for brain pathway reconstruction, and its lead clinical product is a tissue-engineerednigrostriatal pathway that mimics the lost nigrostriatal pathway in patients with Parkinson's disease. This gives patients access to technology that specifically reconstructs brain pathways rather than just masking symptoms temporarily.Innervace was established in 2018 by in Philadelphia, Pennsylvania